glp 1 korea JW Pharmaceutical secures GLP-1 drug rights in $81m deal Korean Obesity Drugs Target Year-End
Description
Empagliflozin ameliorates type 2 diabetes-induced ultrastructural remodeling of the neurovascular unit and neuroglia in the female db/db mouse
ADDF catalyzes and funds drug discovery and drug development for cognitive aging and Alzheimers disease
(Oxf.) 64 , 8690 (2006)
For people without diabetes, insulin and glucagon work as a team, to keep blood sugar in balance
